Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Alex I, Halpern"'
Publikováno v:
Journal of Respiration, Vol 4, Iss 3, Pp 158-162 (2024)
Primary pulmonary myxoid sarcoma (PPMS) is a rarely reported, low-grade malignant endobronchial tumor. We describe a case of PPMS in an asymptomatic 47-year-old female. We highlight the clinical and pathologic aspects of PPMS and its relationship wit
Externí odkaz:
https://doaj.org/article/d6aeb05982584cbf9e1301f6e8e3569a
Publikováno v:
Journal of Endovascular Resuscitation and Trauma Management, Vol 6, Iss 3 (2023)
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a valuable tool for management of life-threateningtruncal hemorrhage. However, prolonged use of REBOA is limited by the ischemia that it causes distalto the occlusion. Partial REBOA
Externí odkaz:
https://doaj.org/article/d0835851e6114c51be5f90362f5ead2a
Publikováno v:
Lung India, Vol 39, Iss 6, Pp 575-577 (2022)
Dendriform pulmonary ossification (DPO) is a rare condition characterised by the formation of bones in lung tissues. This case report describes the first reported case of DPO in a patient with sickle cell disease (SCD), identifying DPO as a potential
Externí odkaz:
https://doaj.org/article/5a24785d6f184abd957385d66401073d
Publikováno v:
Acta Neurologica Belgica. 121:1513-1518
Alemtuzumab is a monoclonal anti-CD52 antibody prescribed to treat relapsing–remitting multiple sclerosis (RRMS). Alemtuzumab affects the balance of the immune system by depleting circulating lymphocytes, leading to the formation of a new immune re
Publikováno v:
Gaitposture. 92
Background Like many physiologic processes, time-of-day may influence postural control and gait. A better understanding of diurnal variations in postural control and gait may help to improve diagnoses, reduce falls, and optimize rehabilitation and tr
Publikováno v:
Journal of neuroimmunology. 344
Neuroaxonal injury and loss result in the release of cytoskeleton components, including neurofilaments, into the cerebrospinal fluid and peripheral blood. Once released, neurofilaments are highly immunogenic, inducing a specific antibody response. An
Publikováno v:
Acta neurologica Belgica. 121(6)
Alemtuzumab is a monoclonal anti-CD52 antibody prescribed to treat relapsing-remitting multiple sclerosis (RRMS). Alemtuzumab affects the balance of the immune system by depleting circulating lymphocytes, leading to the formation of a new immune repe
Publikováno v:
Journal of Respiration (JoR); Sep2024, Vol. 4 Issue 3, p158-162, 5p
Publikováno v:
Research in Sport Medicine & Technology; 2024, Vol. 22 Issue 27, p96-114, 19p
Publikováno v:
Medical Imaging Week; 12/19/2024, p537-537, 1p